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Application of L-glutamate activates ionic currents in
voltage-clamped Xenopus oocytes expressing cloned human
excitatory amino acid transporters (EAATs). However, even
in the absence of L-glutamate, the membrane conductance
of oocytes expressing EAAT1 was significantly increased
relative to oocytes expressing EAAT2 or control oocytes.
Whereas transport mediated by EAAT2 is blocked by the
non-transported competitive glutamate analog kainate <.K.
= 14 #JM), EAAT1 is relatively insensitive <X. > 3 IDM). Substitution of a block of 76 residues from EAAT2 into EAAT1,
in which 18 residues varied from EAAT1, conferred high
affinity kainate binding to EAAT1, and application ofkainate to oocytes expressing the chimeric transporter blocked
a pre-existing monovalent cation conductance that displayed a permeability sequence K+ > Na+ > Li+ » choline+. The results identify a structural domain of glutamate
transporters that influences kainate binding and demonstrate the presence of a constitutive ion-selective pore in
the transporter.

Transport of L-glutamate in the central nervous system and
periphery is mediated by a family of membrane proteins postulated to contain from 6 to 10 transmembrane domains (for
review, see Ref. 1). An important goal in understanding the
molecular basis of transporter function is the identification of
the structural domains involved in substrate recognition and in
the formation of the pore or conduction pathway through which
amino acids and other ions pass. Glutamate uptake is accompanied by an influx of sodium ions and an effiux of potassium
and hydroxyl ions (2-5). Voltage clamp recording from cells
with sufficiently high transporter density can be used to measure membrane currents associated with glutamate uptake. A
stoichiometry proposed for uptake involves co-transport of
2Na+:1Glu- with countertransport of 1 K+ and 1 OH-, resulting in translocation of one net positive charge (5). However,
recent studies of a cloned human glutamate transporter have
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demonstrated that the quantity of charge translocated with
glutamate is voltage-dependent (6). This variable charge stoichiometry occurs as a consequence of an additional current
arising from a thermodynamically uncoupled chloride flux activated by transporter substrates (7, 8). Different transporter
subtypes exhibit intrinsic differences in the magnitude of the
chloride flux relative to flux of glutamate (7).
In addition to differences in ion conduction properties, pharmacological differences exist between the human excitatory
amino acid transporter subtypes. Many compounds that inhibit
radiolabeled glutamate transport (e.g. serine 0-sulfate,
L-trans-pyrrolidine-2,4-dicarboxylic acid, L-cysteic acid, and Daspartate) also induce inward currents, suggesting that they
act as competitive substrates for transport (9). In contrast,
kainate and dihydrokainate, two conformationally restricted
glutamate analogues (10), selectively and competitively block
transport of glutamate by the EAAT2 1 subtype but are not
themselves transported. EAAT1 and EAAT3 are insensitive to
these compounds (Ki > 3 mM) (9). Schild analysis of the inhibition of EAAT2 by kainate has demonstrated that the Kd is
relatively voltage-independent, which suggests that kainate
binds to an external site on the transporter outside the membrane electric field (6). The competitive action of kainate with
respect to glutamate (9) and similar voltage independence of
the Km for glutamate activation2 suggest that kainate may
interact with EAAT2 at the same site in the outer pore of the
transporter where glutamate first binds.
Studies on various cloned sodium-dependent transporters
have demonstrated the presence of substrate-independent currents (11-14), suggesting that these carriers possess intrinsic
pores through which ions pass (for review see Ref. 15). Identification of differences in pore conduction properties between
the transporter subtypes will facilitate identification of residues involved in forming the pore structure. In this study we
demonstrate that EAAT1, but not EAAT2, allows substrateindependent ion fluxes. We have constructed a chimeric transporter that mediates a glutamate-independent conductance
blocked by kainate, thereby identifying a domain involved in
substrate binding and allowing analysis of the voltage dependence and ionic selectivity of this substrate-independent
current.
EXPERIMENTAL PROCEDURES
Construction of a Chimeric Transporter-An in vivo recombination

procedure (17) was used to construct chimeric glutamate transporters.
The EAAT1 and EAAT2 cDNAs were cloned in tandem into the pCMV
plasmid (9) with a unique Xbai site between the cDNAs. The tandem
construct was linearized with Xbai, and 100 ng of DNA was used to
transform competent DH5a cells. Colonies were screened for plasmids
that contained a single eDNA and sequenced to determine the junction
sites (Sequenase, U. S. Biochemical Corp.). A number of plasmids were
isolated, and all the chimeras generated using this method had junction
sites within a highly conserved domain from serine 366 to glutamine
415 (EAAT1 numbering). One of these chimeras contained an EAAT1
sequence at the amino terminus and junctioned with EAAT2 after
serine 366. An EcoRI site was incorporated into the EAAT2 segment in
this chimera at a position corresponding to an endogenous EcoRI site in
EAAT1 (residues 442-443), and this construct was used to generate a
three-part chimera using a polymerase chain reaction-based strategy.
Briefly, an antisense oligonucleotide incorporating silent base changes
1
The abbreviations used are: EAATl, EAAT2, and EAAT3, human
excitatory amino acid transporters 1-3; ,.,s, microsiemens.
2
M. Kavanaugh, unpublished observations.
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FIG. 1. EAATl mediates an uncoupled ion flux. A, current-voltage plots of oocytes 4 days following injection of equal amounts of eRNA
encoding EAATl (open circles), EAAT2 (open squares), or uninjected controls (filled circles). Data points represent mean ± S.E. (n = 6). B, voltage
dependence of glutamate-independent current in oocytes expressing EAAT1 obtained by subtraction of the mean current-voltage curve of
uninjected oocytes from that of oocytes expressing EAATl. C, the amplitude of the uncoupled current in individual oocytes between 1 and 5 days
following injection of EAATl cRNA (measured as the difference in chord conductance compared with matched control oocytes) is proportional to
the level of expression of the transporter (measured as the amplitude of the current elicited by 300 IJ.M L-glutamate at -100 m V) in the same
oocytes.
to introduce the EcoRI site was paired with a sense oligonucleotide
corresponding to the vector polylinker and used in a polymerase chain
reaction with the chimera as template. The resulting product was
subcloned into EAAT1, and the entire coding region was sequenced to
confirm the structure of the construct. The three-part chimera, termed
E1-2-1, was subcloned into pOTV for oocyte expression (9).
Electrophysiological Recording-50 ng of capped eRNA transcribed
with T7 polymerase from each of the eDNA constructs was injected into
defolliculated stage V Xenopus oocytes. Two to seven days later transport was measured by two-electrode voltage clamp recording, and kinetic analyses were performed as described previously (16). In experiments involving ion substitution, sodium was partially replaced with
equimolar choline, lithium, or potassium. The permeabilities of test
ions relative to Na+ were determined from the shift in reversal potential, Ll. V, of the kainate-sensitive leak current induced by substitution of
one-half the extemal sodium with ion X from a modified form of the
Goldman-Hodgkin-Katz equation, PxfPNa = 2(exp(Ll.VF/RT))- 1. Mean
shifts for each test ion were calculated by measurement of reversal
potentials in 4-6 oocytes following measurement in control (ND96)
solution. In experiments in which the chloride concentration was altered, chloride was substituted with either gluconate or methane sulfonate. To avoid offset potentials, a 3 M KCllagar bridge was used to
connect the bath to ground via a 3 M KCl reservoir containing a silver/
silver chloride electrode.

RESULTS

Substrate-independent Ion Flux-In order to test for the
presence of substrate-independent ionic currents mediated by
the EAAT1 and EAAT2 subtypes, the membrane conductance
of oocytes expressing these transporters was compared with
the conductance of uninjected oocytes in the absence of amino
acid (Fig. lA). The chord conductance (measured between -40
and +40 mV) in a group ofuninjected control oocytes was 1.8:!::
0.4 f.LS (mean :!:: S.E., n = 6). In oocytes from the same group
that expressed EAAT2, the chord conductance was unchanged
from control (1.9 :!:: 0.4 f.LS; n = 6), while in oocytes expressing
comparable levels of EAAT1, this value was increased significantly (3.4 :!:: 0.6 f.LS; n = 6; p < 0.05). Similar results were seen
in different batches of oocytes from three frogs. Subtraction of
the mean current-voltage relationship of uninjected oocytes
from that of oocytes expressing EAAT1 revealed the voltage
dependence of the uncoupled ion flux (Fig. 1B). This current
was approximately linear over the voltage range -100 to +40
mV and reversed at -16.9:!:: 4.9 mV (n = 8). In order to test
whether the glutamate-independent current in oocytes expressing EAAT1 was mediated by the transporter, the difference in conductance from the controls was compared with the
amplitude of the current elicited by 300 f.LM L-glutamate at
-100 m V in oocytes expressing different levels of transporter.
There was a linear correlation in individual oocytes (Fig. 1C),
demonstrating that the amplitude of the glutamate-independent current was related to the transporter expression level

= 0.89). These results suggest that EAAT1, but not EAAT2,
mediates a substrate-independent ion flux.
Expression and Kinetic Parameters of a Chimeric Transporter-Kainate competitively antagonizes the EAAT2-mediated current induced by L-glutamate with a Kd of 14 f.LM but has
no effect on the steady state current in the absence of glutamate at membrane potentials between -160 mV and +80 mV
(6). In contrast to EAAT2, glutamate transport by EAAT1 is
relatively insensitive to kainate (9). Application of up to 3 mM
kainate alone to oocytes expressing EAAT1 does not induce any
steady-state current over this voltage range (results not
shown). In order to further investigate the properties of the
glutamate-independent current mediated by EAAT1 and to
identify domains involved in the interaction of the transporter
with kainate, chimeric transporters were constructed and assessed for their kainate sensitivity. One such chimera, termed
E1-2-1, is comprised of the EAAT1 sequence from the amino
terminus through Ser-366 followed by the EAAT2 sequence
through Ala-441, followed by the EAAT1 sequence through the
carboxyl terminus (Fig. 2). E1-2-1 contains 18 residues from
EAAT2 between Ser-366 and Ala-441 that differ from the corresponding EAAT1 residues. Injection of RNA transcribed from
the E1-2-1 chimeric eDNA into oocytes resulted in a >10-fold
increase in 3 H-labeled L-glutamate uptake (data not shown).
Application of glutamate to voltage-clamped oocytes expressing
E1-2-1 resulted in inward currents similar to those observed in
oocytes expressing the parent transporters (Fig. 3). The Km for
L-glutamate exhibited by the chimeric transporter was 9 :!:: 3
f.LM (n = 6), slightly lower than that for EAAT1 (19:!:: 3 f.LM) and
EAAT2 (17 :!:: 2 f.LM). Because the substrate serine 0-sulfate
displays marked differences in kinetic parameters between
EAAT1 and EAAT2 (9), chimera-mediated currents induced by
this compound were examined. EAAT1 displayed a Km of 35 :!::
2 f.LM for serine 0-sulfate and an /max (relative to glutamate) of
1.02 :!:: 0.05, whereas the corresponding values for EAAT2 were
237:!:: 14 f.LM and 0.54:!:: 0.02. TheKm and/max values for serine
0-sulfate transport by E1-2-1 were 17 :!:: 3 f.LM and 1.0:!:: 0.1 (n
= 5), suggesting that the structural domain of the chimera
involved in determining the kinetic parameters for substrate
translocation may be comprised of EAAT1-derived sequences.
Kainate Actions on the Chimeric Transporter-In contrast to
EAAT1 and EAAT2, application of kainate to oocytes expressing the E 1-2-1 chimeric transporter generated a small outward
current at -60 mV (Fig. 3C). This outward current was increased in a dose-dependent and saturable fashion by kainate
(EC 50 = 120 :!:: 16 f.LM at -60 mV; n = 4). In addition, coapplication of 10 f.LM glutamate with 3 mM kainate to the E12-1 chimera similarly resulted in an outward current rather
(r
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FIG. 2. A, schematic diagram of the chimeric EAAT1/EAAT2 transporter El-2-1. Filled areas correspond to the EAATl eDNA sequence, and the
open area corresponds to the EAAT2-derived domain inserted into EAATl (see "Experimental Procedures"). Lines above represent major
hydrophobic domains identified using the Goldman-Engelman-Steitz algorithm (MacVector). B, predicted amino acid sequences of EAATl and
EAAT2 corresponding to the substituted domain and junction region (numbers correspond to residues in EAATl). Dashes reflect identical residues
between EAATl and EAAT2.
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FIG. 3. Substitution of a block of residues from EAAT2 into
EAATl confers kainate sensitivity to the chimeric transporter
El-2-1. Application of kainate alone does not induce currents in
either EAATl (top) or EAAT2 (middle), while co-application of kainate with glutamate blocks the transport current mediated by EAAT2
but not EAATl. Application of kainate alone or co-applied with glutamate resulted in an outward current in cells expressing El-2-1 as
a result of blockade of a constitutive uncoupled current in addition to
block of the glutamate-induced current (see text). Oocytes were voltage clamped at -60 mV and superfused with compounds for duration
indicated by the bars.

than a simple block of the inward transport current as seen
with EAAT2. The outward current induced by kainate at -60
m V resulted from a conductance decrease due to the block of a
constitutive inward current, as revealed by subtraction of the
current-voltage plot in the presence of kainate from that in its
absence (Fig. 4A). The kainate-sensitive current reversed direction at -17.9:!:: 1.0 mV (n = 16) in ND96 bathing solution,
similar to the reversal potential of the EAAT1-associated uncoupled flux ( -16.9 :!:: 4.9 m V, Fig. lB). Thus, the small segment ofEAAT2 sequence in the E1-2-1 chimera confers sensitivity of the uncoupled current to block by kainate.
The nature of the uncoupled current through the chimeric
transporter was examined by ion substitution experiments.
Partial replacement of Na+ out by choline (reducing [Na+lout
from 100.5 to 22.5 mM) caused a 38.2 :!:: 4.2 m V (n = 6) shift in
the reversal potential, indicating that sodium ions contribute to
the substrate-independent leak current. A plot of the reversal
potential of the current blocked by kainate versus the logarithm of the extemal sodium concentration revealed that the
reversal shifted 58.2 mY/decade change in [Na+] in accord
0

,

;; -20

200

-600

~

.s

=
..

!
]-40

=

~

..."'

~

~ -60

..."

"~
~

-80
10

100
[Na+lout (mM)

FIG. 4. A, voltage dependence of L-glutamate-independent (uncoupled) and L-glutamate-dependent currents mediated by the chimeric
El-2-1 transporter. The glutamate-induced current in a representative
oocyte was obtained by subtraction of the current-voltage curve in the
absence ofL-glutamate from that in the presence of300 p,M L-glutamate;
the uncoupled current (in the same cell) was obtained by subtraction of
the current-voltage curve in the presence of 5 mM kainate from that in
the absence of kainate. B, the kainate-sensitive leak conductance is
carried by Na + ions. The reversal potential of the kainate-sensitive
uncoupled currents was measured as in A using external bath solution
(ND96) with [K+] = 0 and in which [Na+] was varied by equimolar
substitution with choline+. The line shows least squares fit to data
points (mean ± S.E.; n = 5) with a slope of 58.2 mV.

with the prediction of the Nemst equation for a Na+-selective
electrode (Fig. 4B). The monovalent cation selectivity of the
uncoupled conductance was further studied by equimolar replacement of one-half the external N a+ with K+, Li +, or choline. From the reversal potential shifts, the permeability sequence was determined to be K+ (1.64) > Na+ (1) > Li+ (0.83)
>> choline ( <0.04).
Substitution of Cl-out with gluconate or methanesulfonate
had no effect on the reversal potential of the uncoupled current
(n = 5). However, after depletion of intracellular chloride by
16-h incubation in gluconate-substituted medium, removal of
extracellular chloride reversibly abolished the kainate-sensitive uncoupled current (n = 5). These results indicate that,
although chloride ions are not permeant, they are required for
expression of the uncoupled monovalent cation current. When
measured in chloride-free conditions to abolish the leak current, kainate blocked the inward current induced by 30 1-LM
L-glutamate with a K; of 97 ± 18 1-LM (n = 3), similar to the
potency observed for the inhibition of the substrate-independent leak current in the normal ND96 bath solution (126 :!:: 6
1-LM). This result is consistent with the hypothesis that block of
the leak conductance and glutamate transport are both mediated by kainate binding at a single site on the transporter.
DISCUSSION

Comparison ofthe membrane conductance of control oocytes
with oocytes expressing EAAT1 and EAAT2 suggests that
EAAT1, but not EAAT2, mediates an ionic flux in the absence
of glutamate. This uncoupled flux is likely to be mediated
directly by the transporter since its amplitude is proportional

Glutamate Transporter Ion Fluxes and Binding Domains
to the level of transporter expression as measured by the glutamate-induced current. Using cDNAs encoding the human
EAAT1 and EAAT2 subtypes, a chimeric glutamate transporter was constructed that is sensitive to the EAAT2-selective
blocker kainate. The chimeric transporter is composed predominantly of EAAT1, with the EAAT2 sequence substituted between the seventh and ninth hydrophobic domains (residues
366-441; Fig. 2). This transposed domain encompasses a
highly conserved region among members of the glutamate
transporter family. For example, the motif FIAQ (residues
415-418) is conserved among the rat homologs of EAAT1
(GLAST (18)) and EAAT2 (GLT-1 (19)), the rabbit homolog of
EAAT3 (EAAC1 (20)), and the Escherichia coli glutamate
transporter gltP (21). Within the chimeric sequence derived
from EAAT2, there are 18 residues that differ from the corresponding residues in EAATl. Substitution of this discrete domain conferred a >50-fold increase in affinity for kainate.
However, because the affinity ofkainate is still 7-8-fold lower
than that observed for EAAT2, it is likely that additional amino
acid residues influence kainate sensitivity. The study of further
chimeras in conjunction with site-directed mutagenesis will be
required to determine the precise role of these and other residues in the interaction of kainate with the transporter.
The kainate sensitivity of the chimeric transporter has allowed identification of the glutamate-independent current as a
flux of monovalent cations through the transporter. Substrateindependent currents have been observed to be mediated by
cloned sodium-dependent transporters for glucose (11), serotonin (12), y-aminobutyric acid (13), dopamine (14), and phosphate.3 Similar to results in the present study, a sodium-dependent leakage current attributed to the glutamate
transporter(s) endogenous to salamander retinal glial cells has
also been reported (22). The presence of uncoupled currents in
various sodium co-transporters may provide clues about the
structural requirements for the permeation path involved in
translocation of large substrate molecules in addition to small
inorganic ions. The similarity of the inhibition constants for
kainate block of the glutamate-dependent and -independent
currents suggests that the ions that carry the uncoupled current are likely to permeate the same pore region of the transporter as glutamate. While transporter-mediated substrate
translocation is commonly modeled by an alternating access
scheme (23), the permeation and possible gating mechanisms
underlying substrate-independent ion fluxes are not well understood. The steady-state uncoupled cation conductance of the
glutamate transporter is relatively insensitive to membrane
3

E. Klamo and M. Kavanaugh, unpublished observations.
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potential. Nevertheless, the requirement of the cation flux for
chloride suggests a possibility of gating, perhaps via an allosteric effect of chloride binding. Alternatively, interactions between cations and chloride may occur in the transporter pore as
have been observed in a neuronal chloride channel (24). Although both EAAT1 and EAAT2 mediate a chloride flux, this
flux requires amino acid for activation (7) and is thus distinguished from the uncoupled cation current that occurs in the
absence of amino acid. Further work to elucidate the molecular
mechanisms underlying these fluxes, including localization of
the precise residues that comprise the permeation pathway,
will allow the construction of increasingly more detailed models
of transport.
Acknowledgments-We thank Jacques Wadiche for discussion and
Weibin Zhang for preparation of Xenopus oocytes.
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